Literature DB >> 18662870

Compliance with anti-infective preventive measures: A multicentre survey among paediatric oncology patients.

Thomas Lehrnbecher1, Hans-Jürgen Laws, Alexandra Boehm, Michael Dworzak, Gisela Janssen, Arne Simon, Andreas H Groll.   

Abstract

BACKGROUND: Infections are significant causes of morbidity and mortality among immunocompromised patients, but little is known about the adherence by the paediatric cancer patients to preventive anti-infective interventions.
METHODS: A voluntary and anonymised questionnaire was distributed to all patients, completing intensive anticancer therapy. Compliance was analysed by using a panel of eight commonly recommended preventive interventions and semi-quantitative scoring of adherence by the patient and/or its caretaker. Satisfaction with information and belief in the efficacy of the interventions were similarly assessed. Relationships of these factors to compliance were explored by using an overall compliance score and non-parametric correlation and/or ANOVA and logistic regression, respectively.
RESULTS: In 216 children and adolescents (mean age: 8 years; 94 girls) included in the study, compliance rates were the highest for food restriction (89.3%), the use of topic antimycotics (88.2%) and trimethoprim/sulfamethoxazole (86.6%), and the lowest for the use of face masks (68.8%), antiseptic mouth rinses (67.1%), non-absorbable antibiotic agents (66.5%) and restrictions in social contacts (65.5%). The most frequent reasons for drug non-compliance were forgetfulness and patient refusal. Compliance correlated with haematological malignancy, younger age and belief in its efficacy, but not with the perceived degree of information, burden of interventions and overall satisfaction with quality of information and medical care.
CONCLUSION: Compliance to recommended anti-infective prophylactic interventions was variable and correlated with haematological malignancy, younger age and belief in efficacy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662870     DOI: 10.1016/j.ejca.2008.06.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Vaccination against influenza at a European pediatric cancer center: immunization rates and attitudes among staff, patients, and their families.

Authors:  Aleksandra Pettke; Sophie Jocham; Andreas Wiener; Andreas Löcken; Judith Groenefeld; Martina Ahlmann; Andreas H Groll
Journal:  Support Care Cancer       Date:  2017-07-21       Impact factor: 3.603

2.  Variations in non-pharmacological anti-infective measures in childhood leukemia--results of an international survey.

Authors:  Thomas Lehrnbecher; Richard Aplenc; Fernanda Rivas Pereira; Alvaro Lassaletta; Désirée Caselli; Jerzy Kowalczyk; Julia Chisholm; Lillian Sung
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

3.  Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation.

Authors:  Joshua Wolf; Monica A Slavin
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

4.  Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.

Authors:  Lars Tramsen; Emilia Salzmann-Manrique; Konrad Bochennek; Thomas Klingebiel; Dirk Reinhardt; Ursula Creutzig; Lillian Sung; Thomas Lehrnbecher
Journal:  J Clin Oncol       Date:  2016-06-06       Impact factor: 44.544

5.  Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.

Authors:  Hanumantha R Pokala; David Leonard; Jennifer Cox; Pat Metcalf; John McClay; Jane Siegel; Naomi Winick
Journal:  Pediatr Blood Cancer       Date:  2013-08-23       Impact factor: 3.167

Review 6.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

Review 7.  Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials.

Authors:  M C Ethier; M Science; J Beyene; M Briel; T Lehrnbecher; L Sung
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.